Document Detail

Use of recombinant granulocyte colony-stimulating factor in Fanconi's anemia.
MedLine Citation:
PMID:  9658728     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND OBJECTIVE: Granulocyte colony-stimulating factor (G-CSF) has been shown to improve the neutropenic status of patients with bone marrow failure. The side effects in prolonged treatment still need to be determined. DESIGN AND METHODS: We have studied the efficacy and the long-term side effects of G-CSF in four patients with Fanconi's anemia and severe neutropenia. RESULTS: Three patients responded with an increase in their absolute neutrophil count; neither improvement in platelet count and hemoglobin concentration nor effect on transfusion requirements was seen. CFU-GM and BFU-E were undetectable before, during and after treatment. Responders showed an important reduction in number and severity of infections, with a marked improvement of clinical status. The fourth patient developed acute myeloid leukemia after 4 weeks of G-CSF treatment. During maintenance, one patient was treated with G-CSF for 18 months, until she received bone marrow transplantation, without presenting side effects. In the second responding patient G-CSF treatment was stopped because of appearance of immature cells in peripheral blood and myeloid blasts in bone marrow. The third responding patient presented immature peripheral myeloid cells during the third year of G-CSF treatment: disappearance of immature cells was observed after G-CSF reduction. In two cases FISH analysis revealed monosomy 7 after G-CSF treatment. INTERPRETATION AND CONCLUSIONS: G-CSF use results in an improvement of clinical status, but long term administration may cause adverse experiences and requires a close hematological monitoring.
P Scagni; P Saracco; F Timeus; L Farinasso; M Dall'Aglio; E M Bosa; N Crescenzio; M Spinelli; G Basso; U Ramenghi
Related Documents :
12725258 - Role of splenectomy in chronic idiopathic thrombocytopenic purpura.
9658728 - Use of recombinant granulocyte colony-stimulating factor in fanconi's anemia.
24180348 - Comparing long term impact on ovarian reserve between laparoscopic ovarian cystectomy a...
17171488 - Spleen-preserving distal pancreatectomy with excision of splenic artery and vein: a cas...
10823598 - Follow-up study of severe slipped capital femoral epiphysis treated with dunn's osteotomy.
7989518 - Assisted hatching with or without bovine oviductal epithelial cell co-culture for poor ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Haematologica     Volume:  83     ISSN:  0390-6078     ISO Abbreviation:  Haematologica     Publication Date:  1998 May 
Date Detail:
Created Date:  1998-08-07     Completed Date:  1998-08-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0417435     Medline TA:  Haematologica     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  432-7     Citation Subset:  IM    
Dipartimento di Scienze Pediatriche e dell'Adolescenza, Università di Torino, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Fanconi Anemia / complications,  drug therapy*
Granulocyte Colony Stimulating Factor, Recombinant / therapeutic use*
Neutropenia / drug therapy*,  etiology
Reg. No./Substance:
0/Granulocyte Colony Stimulating Factor, Recombinant

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus...
Next Document:  Home treatment of deep vein thrombosis: a two-years experience of a single institution.